Yunnan Baiyao
00053855.221.02% ( +0.56 )
Delay Closed: Nov 13, 15:00:00News
The market value of the hundred billion is in jeopardy! After a 20% plunge in profits, how will "Chinese medicine Moutai" ZZPZH turn the tide?
Wallstreetcn·- The traditional Chinese medicine industry is at a turning point in 2025, with nearly one-third of listed companies reporting revenue growth, but less than half achieving profit increases. - The recent financial report from Pianzaihuang revealed a significant decline in revenue and net profit, confirming the industry's struggles as reliance on price increases and unique products wanes. - As the market shifts, the industry must explore new growth strategies beyond price hikes, facing challenges such as rising raw material costs and changing consumer behavior.